278 related articles for article (PubMed ID: 26351036)
1. The relationship of breast density in mammography and magnetic resonance imaging in high-risk women and women with breast cancer.
Albert M; Schnabel F; Chun J; Schwartz S; Lee J; Klautau Leite AP; Moy L
Clin Imaging; 2015; 39(6):987-92. PubMed ID: 26351036
[TBL] [Abstract][Full Text] [Related]
2. The relationship of breast density in mammography and magnetic resonance imaging in women with triple negative breast cancer.
Mema E; Schnabel F; Chun J; Kaplowitz E; Price A; Goodgal J; Moy L
Eur J Radiol; 2020 Mar; 124():108813. PubMed ID: 31927471
[TBL] [Abstract][Full Text] [Related]
3. The relationship of obesity, mammographic breast density, and magnetic resonance imaging in patients with breast cancer.
Gillman J; Chun J; Schwartz S; Schnabel F; Moy L
Clin Imaging; 2016; 40(6):1167-1172. PubMed ID: 27572282
[TBL] [Abstract][Full Text] [Related]
4. Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?
Dontchos BN; Rahbar H; Partridge SC; Korde LA; Lam DL; Scheel JR; Peacock S; Lehman CD
Radiology; 2015 Aug; 276(2):371-80. PubMed ID: 25965809
[TBL] [Abstract][Full Text] [Related]
5. Mammographic density, MRI background parenchymal enhancement and breast cancer risk.
Pike MC; Pearce CL
Ann Oncol; 2013 Nov; 24 Suppl 8(Suppl 8):viii37-viii41. PubMed ID: 24131968
[TBL] [Abstract][Full Text] [Related]
6. MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: associations with survival.
Lo Gullo R; Daimiel I; Rossi Saccarelli C; Bitencourt A; Sevilimedu V; Martinez DF; Jochelson MS; Morris EA; Reiner JS; Pinker K
Breast Cancer Res; 2020 Aug; 22(1):93. PubMed ID: 32819432
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.
Sung JS; Corben AD; Brooks JD; Edelweiss M; Keating DM; Lin C; Morris EA; Patel P; Robson M; Woods M; Bernstein JL; Pike MC
Breast Cancer Res Treat; 2018 Nov; 172(2):487-496. PubMed ID: 30140962
[TBL] [Abstract][Full Text] [Related]
8. Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.
Vreemann S; Dalmis MU; Bult P; Karssemeijer N; Broeders MJM; Gubern-Mérida A; Mann RM
Eur Radiol; 2019 Sep; 29(9):4678-4690. PubMed ID: 30796568
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
[TBL] [Abstract][Full Text] [Related]
10. Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.
Savaridas SL; Taylor DB; Gunawardana D; Phillips M
Clin Radiol; 2017 Dec; 72(12):1085.e1-1085.e9. PubMed ID: 28870431
[TBL] [Abstract][Full Text] [Related]
11. Background parenchymal enhancement and fibroglandular tissue on breast MRI in women with high genetic risk: Are changes before and after risk-reducing salpingo-oophorectomy associated with breast cancer risk?
Bermot C; Saint-Martin C; Malhaire C; Sebbag-Sfez D; Mouret-Fourme E; Carton M; Thibault FE
Eur J Radiol; 2018 Dec; 109():171-177. PubMed ID: 30527300
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.
Wu S; Weinstein SP; DeLeo MJ; Conant EF; Chen J; Domchek SM; Kontos D
Breast Cancer Res; 2015 May; 17():67. PubMed ID: 25986460
[TBL] [Abstract][Full Text] [Related]
13. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.
King V; Goldfarb SB; Brooks JD; Sung JS; Nulsen BF; Jozefara JE; Pike MC; Dickler MN; Morris EA
Radiology; 2012 Sep; 264(3):670-8. PubMed ID: 22771878
[TBL] [Abstract][Full Text] [Related]
14. Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging.
King V; Kaplan J; Pike MC; Liberman L; David Dershaw D; Lee CH; Brooks JD; Morris EA
Breast J; 2012; 18(6):527-34. PubMed ID: 23002953
[TBL] [Abstract][Full Text] [Related]
15. Background parenchymal enhancement on breast MRI and mammographic breast density: correlation with tumour characteristics.
Kim MY; Choi N; Yang JH; Yoo YB; Park KS
Clin Radiol; 2015 Jul; 70(7):706-10. PubMed ID: 25824280
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Volumetric K-Means Cluster Segmentation of Fibroglandular Tissue and Skin in Breast MRI.
Niukkanen A; Arponen O; Nykänen A; Masarwah A; Sutela A; Liimatainen T; Vanninen R; Sudah M
J Digit Imaging; 2018 Aug; 31(4):425-434. PubMed ID: 29047034
[TBL] [Abstract][Full Text] [Related]
17. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.
Arasu VA; Miglioretti DL; Sprague BL; Alsheik NH; Buist DSM; Henderson LM; Herschorn SD; Lee JM; Onega T; Rauscher GH; Wernli KJ; Lehman CD; Kerlikowske K
J Clin Oncol; 2019 Apr; 37(12):954-963. PubMed ID: 30625040
[TBL] [Abstract][Full Text] [Related]
18. MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
Bennani-Baiti B; Dietzel M; Baltzer PA
PLoS One; 2016; 11(7):e0158573. PubMed ID: 27379395
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
[No Abstract] [Full Text] [Related]
20. The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue.
Price ER; Brooks JD; Watson EJ; Brennan SB; Comen EA; Morris EA
Eur Radiol; 2014 Jan; 24(1):162-8. PubMed ID: 23982290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
